Polen Capital Charles River Laboratories International, Inc. Transaction History

Polen Capital Management LLC

$38.7 Billion
Q3 2024

A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Polen Capital Management LLC holds 5,504 shares of CRL stock, worth $901,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,504

Previous 5,715 3.69%

Holding current value

$901,500

Previous $1.18 Million 8.14%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $39,659 - $51,756	-211 Reduced 3.69%	5,504 $1.08 Million
Q2 2024 Aug 12, 2024	SELL	$206.39 - $268.73 $71,204 - $92,711	-345 Reduced 5.69%	5,715 $1.18 Million
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $54,543 - $73,279	-268 Reduced 4.24%	6,060 $1.64 Million
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $217,659 - $315,985	1,323 Added 26.43%	6,328 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $9,722 - $10,880	50 Added 1.01%	5,005 $980,000
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $94,426 - $108,068	-514 Reduced 9.4%	4,955 $1.04 Million
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $42,023 - $56,922	-219 Reduced 3.85%	5,469 $1.1 Million
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $204,600 - $259,572	1,038 Added 22.32%	5,688 $1.24 Million
Q3 2022 Nov 04, 2022	SELL	$182.44 - $250.54 $6,385 - $8,768	-35 Reduced 0.75%	4,650 $915,000
Q2 2022 Aug 10, 2022	BUY	$204.13 - $302.4 $956,349 - $1.42 Million	4,685 New	4,685 $1 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

51.8M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track Polen Capital's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.

Account